Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023

SELL
$224.99 - $256.14 $46,122 - $52,508
-205 Reduced 16.98%
1,002 $240,000
Q1 2023

Apr 18, 2023

SELL
$239.75 - $277.0 $50,347 - $58,170
-210 Reduced 14.82%
1,207 $304,000
Q4 2022

Jan 20, 2023

BUY
$241.42 - $282.29 $1,207 - $1,411
5 Added 0.35%
1,417 $0
Q3 2022

Oct 21, 2022

BUY
$247.06 - $1507.4 $13,588 - $82,907
55 Added 4.05%
1,412 $363,000
Q2 2022

Jul 18, 2022

BUY
$237.11 - $299.66 $1,659 - $2,097
7 Added 0.52%
1,357 $343,000
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $131,464 - $161,353
-511 Reduced 27.46%
1,350 $396,000
Q4 2021

Apr 29, 2022

BUY
$292.08 - $329.01 $543,560 - $612,287
1,861 New
1,861 $612,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Sterling Investment Counsel, LLC Portfolio

Follow Sterling Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Counsel, LLC with notifications on news.